For the year ending 2025-12-31, ACTG had $32,839K increase in cash & cash equivalents over the period.
| Cash Flow | 2025-12-31 |
|---|---|
| Net income (loss) including noncontrolling interests in subsidiaries | 24,470 |
| Depreciation, depletion and amortization | 43,348 |
| Accretion of asset retirement obligation | -1,734 |
| Loss on disposal of assets | -169 |
| Compensation expense for share-based awards | 5,738 |
| (gain) loss on foreign currency exchange | 414 |
| Change in fair value of equity securities | 1,092 |
| Loss (gain) on sale of equity securities | -25 |
| Unrealized (gain) loss on derivatives | 3,718 |
| Deferred income taxes | 4,839 |
| Accounts receivable | -664 |
| Inventories | -212 |
| Prepaid expenses and other assets | 5,286 |
| Accounts payable and accrued expenses | 3,143 |
| Royalties and contingent legal fees payable | 1,312 |
| Deferred revenue | 98 |
| Net cash provided by operating activities | 75,242 |
| Acquisition, net of cash acquired and working capital adjustments (note 3) | -1,230 |
| Patent acquisition | 0 |
| Proceeds from sale of floor mat assets | 2,988 |
| Purchases of equity securities | 24,705 |
| Sales of equity securities | 31,357 |
| Purchases of loans receivable | 15,183 |
| Purchases of property and equipment | 2,520 |
| Net additions to oil and gas properties | 14,174 |
| Net cash used in investing activities | -21,007 |
| Repurchase of common stock | 0 |
| Contributions from noncontrolling interest | 0 |
| Borrowings on the benchmark revolving credit facility | 5,000 |
| Paydown of benchmark revolving credit facility | 12,000 |
| Borrowings on the deflecto facility | 0 |
| Paydown of deflecto facility | 15,088 |
| Taxes paid related to net share settlement of share-based awards | 675 |
| Proceeds from exercise of stock options | 30 |
| Net cash (used in) provided by financing activities | -22,733 |
| Effect of exchange rates on cash and cash equivalents | 1,337 |
| Increase (decrease) in cash and cash equivalents | 32,839 |
| Cash and cash equivalents, beginning of period | 273,880 |
| Cash and cash equivalents, end of period | 306,719 |
ACACIA RESEARCH CORP (ACTG)
ACACIA RESEARCH CORP (ACTG)